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ABSTRACT
The double-stranded RNA activated protein kinase DAI
contains an RNA binding domain consisting of two
copies of a double-stranded RNA binding motif. We
have investigated the role of RNA structure in the
interaction between DAI and the structured single-
stranded RNA, adenovirus VA RNA,, which inhibits
DAI activation. Mutations in the apical stem, terminal
stem, and central domain of the RNA were tested to
assess the contribution of these elements to DAI
binding in vitro. The data demonstrate that over half
a turn of intact apical stem is required for the
interaction and that there is a correlation between the
binding of apical stem mutants and their ability to
function both in vivo and in vitro. There was also
evidence of preference for GC-rich sequence in the
proximal region of the apical stem. In the central
domain the correlation between binding and function
of mutant RNAs was poor, suggesting that at least
some of this region plays no direct role in binding to
DAI, despite its functional importance. Exceptionally,
central domain mutations that encroached on the
phylogenetically conserved stem 4 of VA RNA
disrupted binding, and complementary mutations in
this sequence partially restored binding. Measurement
of the binding of wild-type VA RNA, to DAI and p20, a
truncated form of the protein containing the RNA
binding domains alone, under various ionic conditions
imply that the major interactions are electrostatic and
occur via the protein's RNA binding domain. However,
differences between full-length DAI and p20 in their
binding to mutants in the conserved stem suggest that
regions outside the RNA binding domain also
participate in the binding. The additional interactions
are likely to be non-ionic, and may be important for
preventing DAI activation during virus infection.
INTRODUCTION
Adenovirus type 2 (Ad2) virus-associated (VA) RNA! is
required for the maintenance of viral protein synthesis at late times
of infection and it can stimulate protein synthesis in uninfected
cells (1). VA RNA! functions by antagonizing a component of
the host cell's anti-viral defense pathway, the interferon-induced,
double-stranded RNA (dsRNA)-activated protein kinase, DAI
(also known as PI, PK-ds, and PKR) (2-6) . This enzyme is
activated by autophosphorylation, which occurs in the presence
of duplexed dsRNA containing at least 30 base pairs (bp) and
optimally at least 85 bp (7-9) . Such dsRNAs are apparently
produced during viral infection (10). Short RNA duplexes, and
specialized effectors such as VA RNA, prevent DAI activation
and the consequent phosphorylation of its substrate, the protein
synthesis initiation factor eEF-2 (8,9). Phosphorylated eIF-2 traps
a second initiation factor, the guanosine nucleotide exchange
factor (GEF or eIF-2B), leading to an inhibition of protein
synthesis initiation (11 — 15) and suppressing virus replication
(16).
VA RNAi is a short (160 nucleotide) RNA which is
synthesized by RNA polymerase m. It binds to DAI, but unlike
dsRNA it does not activate the enzyme (2,3,17-20).
Furthermore, at relatively high concentrations VA RNAj
prevents the binding of dsRNA and blocks DAI activation (21)
although it does not inhibit the activity of the kinase after it has
been activated (21,22). VA RNAj is formally single-stranded
but it is highly structured, consisting of two base-paired stems,
the terminal and apical stems, connected by a complex stem-loop
structure known as the central domain (23,24). This structure
was initially proposed on the basis of ribonuclease sensitivity
analysis and mutagenic studies (23-25), but more detailed
analysis indicated that the central domain of the original model
had to be reconsidered (26). Comparison of VA RNAs from
different adenovirus serotypes disclosed the existence of two
conserved tetranucleotides, GGGU and ACCC, located in the
central domain (27,28). These tetranucleotides are complementary
to one another and their pairing results in a secondary structure
(Fig. 1) differing slightly in the central domain from that
originally proposed as a result of the formation of a new stem
(stem 4). This structure is consistent with more recent data
obtained with a set of chemical and enzymic probes (29).
The RNA binding site of DAI contains two copies of a dsRNA
binding motif that is shared with a number of other RNA-binding
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proteins (30,31). Although VA RNAT and dsRNA appear to
bind to the same site on DAI (20,30,32), they exert opposing
effects on enzyme activation. Since the mode of action of VA
RNAt is not yet established, two general possibilities can be
entertained: either its binding to DAI differs in some subtle way
from the binding of dsRNA, resulting in the inhibition of enzyme
activation; alternatively, some feature of VA RNAj interferes
with a subsequent step required for autophosphorylation and
activation of DAI. To distinguish between these two possibilities
demands a detailed understanding of the structural requirements
for the binding and activity of VA RNAj. One approach to this
objective is to examine the effects of mutations in the RNA on
its binding and biological activity, but the findings to date have
been equivocal. Our initial study indicated that the activity of
VA RNAj could be separated from its binding ability,
implicating the apical stem as the structure involved in binding
DAI, and the central domain in the inhibition of DAI activation
(23,25). On the other hand, a study of different mutants concluded
that long duplexes, such as the apical stem, are not required for
VA RNAj binding to DAI and that the central domain is the sole
requirement for both activity and binding (33).
Most of the mutants studied in binding assays conducted to
this point contain relatively coarse deletions or substitutions of
large tracts of nucleotides. Since the structure of VA RNAj is
very compact, the possibility exists that these mutations might
affect RNA structure in ways that are difficult to predict or
determine by the methods used. We recently generated a set of
mutants containing smaller, more directed, mutations that are
specific for certain predicted structural features of the apical stem
or central domain, including mutations in the newly discovered
conserved stem 4 (26,28,34). To assess the contribution of VA
RNA! structural features to DAI binding and to resolve the
controversial binding results, we have examined the interaction
of the kinase with a large number of substitution and deletion
mutants in the apical stem and central domain. We conclude that
the primary interaction requires an intact apical stem containing
at least 8 base pairs. Some central domain mutations affect
binding, but generally to a small extent, implying that there are
secondary interactions with the central domain. These interactions
seem to involve regions of DAI outside its RNA binding domain,
suggesting that they may be involved in blocking DAI activation.
MATERIALS AND METHODS
Labeling of VA RNAs
Most of the RNAs were uniformly labeled by transcription of
Dral linearized plasmid pT7VA and its mutant derivatives using
T7 RNA polymerase (19). The Is I series of mutant RNAs were
uniformly labeled by transcription from plasmid pMHVA and
its derivatives using RNA polymerase El (23). The stem 4
mutants were transcribed using 17 polymerase and were labeled
at the 3' end with [32P]-pCp using T4 RNA ligase (35).
Reactions were performed by the addition of master mix
containing all the components required for the labeling reaction
to ensure identical specific activities (approximately 1 x 106
Cerenkov counts/min/^g RNA) and in each case, wild-type Ad2
A RNA! was labeled in parallel. The labeled RNAs were
purified by electrophoresis through denaturing and native
polyacrylamide gels as described previously (19).
Immobilization of DAI. Human DAI was obtained from the
ribosomal salt wash (RSW) of interferon-treated 293 cells (21)
and the RNA binding fragment of DAI (p20) was purified from
E.coli overexpressing the protein (9,36). For binding reactions,
10/tl of RSW or 25ng of p20 were incubated with 0.5/tl of ascites
fluid containing a monoclonal antibody directed against DAI (37)
in buffer BII (38) containing 20mM Tris-HCl, pH7.5, 50mM
KC1, 400mM NaCl, lmM EDTA, lmM DTT, 100 units/ml
aprotinin, 0.2mM PMSF, 20% glycerol, and 1 % Triton X-100.
The immune complexes were isolated by adsorption to an equal
volume of a 10% suspension of protein A-Sepharose beads
(Pharmacia). In later experiments, protein A-Sepharose was
replaced by protein G-Sepharose (Pharmacia) which gave more
efficient recovery of immune complexes without otherwise
affecting the results. After incubation for 10 min at 4°C, the beads
were washed at least six times in buffer BE. The immunosorbent
was prepared in bulk and divided prior to the RNA binding
reactions.
Binding of VA RNAr to DAI
Sepharose beads carrying immobilized DAI or p20 were
equilibrated with RNA binding buffer by washing twice in buffer
A (buffer m of Katze et al. (38)) or buffer B (buffer m of Mellits
etal.{25)). Buffer A contains lOmM Tris-HCl, pH7.4, lOOmM
KC1, 2mM MgCl2, 2mM MnCl2, 10,tM ATP, 7mM 0-
mercaptoethanol, 0. lmM EDTA, 100 units/ml aprotinin and 20%
glycerol. Buffer B contains 25mM Hepes.KOH, pH7.4, lOOmM
KC1, lOmM MgCl2, O.lmM EDTA, lmM DTT, 100 units/ml
aprotinin, lOjtM PMSF and O.lmg/ml RNase-free BSA. VA
RNA (25,000-50,000 Cerenkov counts/min, giving a final
concentration of about 1/tg/ml, approaching that used in DAI
phosphorylation assays) and 100/ig/ml calf liver tRNA
(Boehringer Mannheim) were mixed with the beads in a final
volume of 30/il for 20 min at 30°C in buffer A, or for 5 min
at 30°C followed by 25 min at 4°C in buffer B. Complexes were
washed at least four times with 1 ml of binding buffer
supplemented with 10 /tg/ml calf liver tRNA. Radioactivity bound
to the beads was quantified by Cerenkov counting. In each
experiment, binding was normalized to the binding of wild-type
VA RNAi after subtracting the background binding value
obtained in the absence of DAI. Most experiments also included
the severely disrupted mutant Isl as a control for a mutant RNA
that binds poorly In some cases, bound RNA was recovered and
examined by electrophoresis through a denaturing polyacrylamide
gel: no degradation was detected, and the results were in
qualitative agreement with the radioactivity counted.
Electrophoretic mobility of RNA
Each mutant RNA was mixed with synthetic marker RNAs (9)
and subjected to gel electrophoresis in 8% polyacrylamide gels
containing 7M urea and 0.5XTBE. When the mobility of the
marker RNAs was plotted against chain length, the points fell
on a straight line indicating that these transcripts are devoid of
secondary structure. The plot was used to determine the mobility
for each VA RNA expected for its known chain length. All VA
RNAs migrated more slowly than predicted, and a mobility
retardation factor was calculated by comparison with the actual
mobility measured. The percentage retardation is 100x(l —actual
mobility/expected mobility).
RESULTS
Binding of conserved stem 4 mutants to DAI and p20
Although it is generally agreed that the central domain of Ad2
VA RNA| is essential for the molecule's ability to block DAI
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activation (23—25,33), our previous studies (25) indicated that
the apical stem rather than the central domain, is critical for
binding to DAI. Consistent with this view, DAI apparently binds
VA RNAi in a similar fashion to dsRNA and at the same or a
closely related site (21,30,32). Others, however, have suggested
that the central domain is critical for VA RNAt binding (33) as
well as for its function. Recent work (27,29) led to a revised
structural model containing a more compact central domain (Fig.
1), prompting us to reinvestigate the binding of VA RNAj to
DAI. While the apical stem remains unchanged in the new model,
the central domain contains a new stem (stem 4), composed of
two highly conserved complementary tetranucleotides (27,28).
Stem 4 occupies a key location in the revised structure, forming
a link between the apical stem and the terminal stem in the duplex
axis of the molecule, as well as an important feature of the central
domain.
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Mutations that disrupt and restore base-pairing in stem 4 have
been constructed, as illustrated in Fig. 2A. The mutations LI
and Rl are two-nucleotide substitutions in stem 4a and stem 4b,
respectively, that disrupt base-pairing in stem 4. The combination
of these two mutations forms a double mutant, Ll-Rl, designed
to restore base-pairing and reconstitute the stem. The analysis
of the structure and function of these mutant RNAs is described
elsewhere (28). Here we have examined the effect of the stem
4 mutations on binding to intact DAI and to p20, a truncated
version of the protein consisting of its first 184 amino acids and
containing its RNA binding domain (18,30,32). Although both
the full length kinase and p20 bind VA RNA, efficiently (30),
the functional importance of the central domain suggested that
this region might interact with the catalytic part of the kinase.
Since stem 4 is a highly conserved element of the central domain,
it also seemed possible that disruption of stem 4 might
differentially affect the binding to DAI and p20. As shown in
Figure 2B, LI and Rl both bound to DAI with reduced efficiency
(34% and 20% of wild-type, respectively). Instead of being more
severely affected than the single mutant as would be expected
for independent mutations, the double mutant Ll-Rl bound better
than either single mutant (46% of wild-type). This indicates that
the mutants are structurally compensatory, and supports the
existence and importance of stem 4. Since binding was not fully
restored, however, it is likely that the sequence in stem 4, as
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Figure 1. Secondary structure model of Ad2 VA RNA(. Stem 1 is the terminal
stem, stem 5 and loop 6 comprise the apical stem-loop, and stems 3, 4 and 7
and loops 2, 8, 9 and 10 form the central domain. Stem 4 is phylogenetically
conserved.
Figure 2. Effects of mutations in conserved stem 4 on binding to DAI and p20.
(A) Diagram of mutant sequences, showing the alterations in bold italic type.
(B) Binding of 3' end labeled wild-type and mutant RNAs to immobilized DAI
or p20 in buffer B, expressed relative to that of wild-type RNA. Error bars show
standard errors.
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well as its base pairing, plays a role in binding, as implied by
its evolutionary conservation.
A similar pattern of binding behavior was observed using p20
in place of DAI, but the consequence of disrupting base pairing
in stem 4 was more deleterious than for DAI binding by about
two-fold (Fig. 2B). This observation suggests that p20 binding
is heavily dependent on duplex structure, while regions of DAI
outside the RNA binding domain can partially overcome the effect
of disruptive mutations in stem 4. Consistent with this inference,
intact DAI gives a slightly more extensive footprint on VA
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Figure 3. Influence of KCI and MgCl2 concentrations on the binding of VA
RNA, to DAI and p20. Wild-type VA RNA, was 3' end-labeled and reacted with
immobilized DAI or p20 under buffer B conditions except that either (A) MgCI2
or (B) KCI concentrations were varied. For the pre-wash control in (B), the DAI-
containing immune complexes were washed at the KCI concentration indicated,
then washed twice to bring the KCI concentration back to lOOmM KCI prior to
the RNA binding reaction and subsequent washing at lOOmM KCI. The control
background binding reaction was with protein G-Sepharose only. Error bars show
standard deviations.
than p20 does, implying that regions outside the RNA
binding domain are also in contact with VA RNA] (29).
Influence of binding conditions
The reduced binding of stem 4 mutants to both DAI and p20
indicated that at least part of the central domain is important for
binding, and led us to reexamine the contribution of the apical
stem and central domain to VA RNA, interaction with full-
length DAI. Because of the contradictory results in the literature,
we first compared the binding of wild-type VA RNA] to DAI
under the two sets of binding conditions used previously. Binding
was about 5-fold higher in buffer A (33) than in buffer B (25)
and the background binding ratio between the two buffers,
obtained in the absence of monoclonal antibody, DAI or both,
was also about 5 (data not shown). The most conspicuous
difference between the buffers is that buffer A contains 2mM
MgCl2, 2mM MnCl2 and lOmM ATP, while buffer B contains
lOmM MgCl2 and no MnCl2 or ATP. It has been noted that the
binding of VA RNAj to DAI is reduced significantly in the
absence of Mg2+ (22), so the difference in the concentration of
this ion between buffer A and B could be significant. As shown
in Fig. 3A, binding declined with increasing concentrations of
MgCl2 such that it was about 2.5 times less at lOmM than at
2mM MgCl2. Similar results were obtained with p20 (Fig. 3A).
Since elevated concentrations of this divalent cation reduce the
binding of VA RNAi, we also examined the effect of
monovalent cation concentrations on binding. Fig. 3B shows that
increasing concentrations of KCI also reduced the binding of VA
RNAj to DAI or p20. Pretreatment of immunosorbed DAI with
varying KCI concentrations had no significant effect on the
binding of VA RNA, at lOOmM KCI (Fig. 3B, open squares),
indicating that the immune complex is not disturbed by high salt
concentrations. In view of the strongly basic nature of the RNA
binding region of DAI (30), the salt effects are probably due to
the shielding of electrostatic interactions between the protein and
the RNA. An alternative interpretation, that alterations in VA
RNA, structure are responsible, is less likely since the nuclease
digestion patterns obtained at 2mM and lOmM MgCl2 are
indistinguishable (data not shown).
Prior to testing the full series of VA RNA mutants, we verified
the specificity of binding under the same conditions. Calf liver
tRNA reduced binding slightly, probably by blocking non-specific
interactions, and was therefore routinely included in binding
reactions. The binding of wild-type VA RNAj was greatly
reduced by unlabeled competitor VA RNA] or dsRNA (data not
shown), confirming that VA RNAi and dsRNA interact with
DAI at similar sites. Reciprocal experiments demonstrated that
VA RNAj competes with dsRNA for binding to DAI (21),
although Galabru et al. (22) did not observe a reduction by dsRNA
of VA RNA binding. More recently, however, mutational
analysis of DAI has shown that similar or identical elements and
amino acids are required for dsRNA binding and VA RNAj
binding (18,20,30,32), suggesting that the sites are closely
related, if not one and the same.
Apical stem and central domain mutants
To examine the influence of RNA structure on the binding of
VA RNA] to DAI, we employed two sets of mutants. The first
set contains mutations in the apical stem; the second set contains
mutations in the central domain, together with a truncated form
of the wild-type molecule, Aatn, which lacks the 3' part of the
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terminal stem. The mutations are specified in Table 1 and their
positions on the wild-type secondary structure are illustrated in
Fig. 4. The actual secondary structures of the mutant RNAs were
determined using ribonuclease sensitivity analysis as described
previously (23,25,26,34). The RNAs were all purified by
sequential electrophoresis through denaturing and non-denaturing
gels to remove dsRNA contaminants (19). During purification
it became apparent that some mutations affect the electrophoretic
mobility of the RNA in denaturing gels as reported earlier
(24,25,39,40). To correlate the gel mobility with the structures
of the mutant VA RNA molecules and their binding to DAI in
vitro, we systematically examined the mobility of the RNAs. The
results, which are illustrated in Figure 5 and listed in Table I,
separated the VA RNA mutants into three groups: group I, II
and m RNAs were retarded about 30%, 15% and 5%,
respectively. It is striking that group I contains all the RNAs with
mutations in the central domain, plus A2dl2, Aatll and wild-type
VA RNAj, while the less retarded RNAs were all mutated in
the apical stem.
Aberrant electrophoretic mobility is usually due to denaturation-
resistant secondary structures (41). Since mutations in the central
domain do not cause structural changes in the apical stem (26),
and group I contains the Aatll truncation which lacks a terminal
stem, it is likely that the structural feature responsible for the
retardation lies in the apical stem. The mutant A2dl2 falls into
this group even though it has a deletion of six nucleotides (nts.
73-78) in this stem. Despite the deletion, it is still able to form
an extended, stable apical stem (23,25) and, in fact, A2dl2 RNA
adopts a more compact apical stem-loop structure than wild-type
VA RNA under non-denaturing conditions (25). It is likely that
wild-type VA RNAt and the central domain mutant RNAs adopt
the A2dl2-like structure under the denaturing conditions of the
gel. Consistent with this interpretation, deletions in the apical
stem that prevent the formation of a stem structure result in RNA
mobilities approaching that of a random coil. The two mutants
in group m, del49-60 and del53-S0, display only 7% and 4%
retardation, respectively. Furthermore, mutant RNAs in group
II, which display intermediate mobility, retain the ability to form
Table 1. Sequence and electrophoretic mobility of VA RNA mutants
A) Apical stem mutations.
Wild-type
lsl
lsla
lslb
Isle
lsld
Isle
del49-60
del53-80
del73-84
A2dl2
dll
dl2
dl3
dl4
41
AUCAUGGCGG
51
ACGACCGGGG
61
UUCGAACCCC
71
GGAUCCGGCC
CA--AUC UG-
CA--AUC UG-
xxxxxxxxxx
—xxxxxxxx xxxxxxxxxx xxxxxxxxxx
--xxxxxxxx
- -XXXXXX--
U-xxx
U-xxx
U-xxx
U-xxx
Mobility
81 Retardation
GUCCGCCGUG 33
CAGAU--U-- 17
15
14
16
15
15
7
4
14
29
12
14
14
15
U--U--
CAGAU--U--
CAGA
AAAC--
xxxx
xxxxxxxx--
xxxxxxxxxx
xxxxxxxxxx
stem 5a loop 6 stem 5b
B) Central domain and terminal stem mutations.
Wild-type
dl3
dl4
Is2
Is3
Is3a
Is3b
dell03-109
Is4
subllO-117
delllO-117
subll8-119
subl01,102
sublO2,118,119
subl01,102,118,119
Is5
Aatll
91 101
AUCCAUGCGG
xxxxxx
xxxxxxxxx-
GAUCUGG
UUACCGCCCG
111
CGUGUCGAAC
121
CCAGGUGUGC
131
GACGUCAGAC
CAGAUCUGxG
--GAUCUGxG
CAGAUCUGxG
—xxxxxxx-
AGA
U
-UG-
UCUxxxxxxx
ACACAUC
xxxxxxx
UG-
CA-
-A-
CA-
-UG-
-UG-
-CAGAX UCU
xxxxxxxxxx
stem 7a
33
14
15
30
30
30
30
29
27
31
28
31
30
30
30
32
29
loop 8
stem 7b stem 4b stem 3b stem lb
loop 9 loop 10 loop 2b
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Figure 4. Schematic representation of the mutations. Superimposed on the wild-
type VA RNA, structure, deletions are represented by gaps and substitutions by
thick lines. The mutants are presented in order of decreasing binding efficiency,
ranked as in Table 2. The stippled area outlines the region of wild-type VA RNAj
that is protected from chemical and nuclease attack by DAI (29).
part of the structure. They all contain disruptions toward the base
of the apical stem but they can still form a short hairpin structure
by pairing the CCGGGG and CCCCGG sequences (nucleotides
55-60 and 67-72), as in A2dl2 RNA. This residual structure
presumably accounts for the approximately 15% retardation that
characterizes the group. Remarkably, even small changes, such
as the two nucleotide mutations in M b and the compensating
mutations of /sic which fully restore the ability to pair in the
lower part of the apical stem, result in reduced gel retardation.
This observation reinforces the earlier suggestion that the basal
part of the apical stem plays an important role in VA RNA
structure and function (34), a conclusion that is consistent with
footprinting data (29) and is tested below with respect to DAI
binding.
Binding of apical stem mutants to DAI
Because of the substantial quantitative difference between buffers
A and B in wild-type VA RNA] binding efficiency, we
considered the possibility that there might also be qualitative
differences between the buffers with respect to the effect on
binding of mutations in VA RNA structure. Therefore, all mutant
RNAs were tested for their ability to bind to DAI in both buffers.
Wild type DAI, rather than p20, was employed in these
experiments since it appears that regions outside the RNA binding
domain contribute to the binding. The binding efficiency for each
mutant RNA, expressed as a percentage of wild-type VA RNA!
binding, is presented in Fig. 6A and the results are summarized
in order of binding efficiency in Table 2a and Fig. 4.
With the exception of A2dl2, apical stem mutants all displayed
reduced binding efficiency. In the most severe cases, dl\ and
ls\, binding was reduced to about 10% of the wild-type level,
equivalent to the binding observed with RNAs of unrelated
sequence and structure (data not shown). In general, binding
efficiency correlated with the residual ability of the mutant RNA
to form an apical stem structure. Thus, among the deletion
mutants, the apical region of dl\ RNA is almost completely
opened to form a large loop; in buffers A and B, respectively,
this RNA bound only 9% and 12% as well as the wild-type
control. Mutant del53-S0 RNA, which also possesses a severely
truncated apical stem (only 8 base pairs) but does not have the
distended apical loop of dl\ (34), also bound very weakly, as
did ls\ and del49-6O RNAs which are severely disrupted in the
apical stem as well as in the central domain. The mutant de/73-84
RNA, in which the right side of the apical stem is deleted,
rearranges to form a longer apical stem (13 base pairs) with a
small bulge on the left side of the stem (34); accordingly, this
RNA bound significantly better (36% and 37% of control).
Taking these results together, it seems that truncation of the stem
reduces binding and that more than 8 base pairs of apical stem
are required for the efficient binding of VA RNA] to DAI. Not
all deletions in the apical stem were deleterious, however; A2dl2
RNA, which exhibits a different, more compact pairing in the
apical stem and a central domain structure similar to that of wild-
type (23,25), bound to DAI even more efficiently than wild-type
RNA (140% and 170%). Therefore, mutant RNA can bind
efficiently provided that an extended apical stem is retained.
The series of substitution mutants lsla—Isle introduce more
subtle changes within the lower part of the apical stem. These
RNAs are less disturbed in the apical stem region and displayed
correspondingly less aberrant binding properties. Mutants /sib
and Isle RNAs are essentially wild-type in structure according
to nuclease sensitivity analysis although their gel behavior
revealed some differences. Their binding was reduced only
slightly (63 and 82% of control). Mutations lsla, Isd and Isle,
which introduce interior bulges that interrupt the continuity of
the apical stem, reduced RNA binding to a greater extent
(26-68% of control). Thus, the stability and continuity of the
apical stem make a major contribution to the binding capacity
of VA RNA] to DAI, corroborating our previous conclusion
(25) but not that of others (33).
Binding of central domain mutants to DAI
It is generally agreed that mutations within the central domain
abrogate the function of VA RNA, (23-25,33), but there are
contradictory views as to their impact on DAI binding. Our data
indicated that central domain mutations only slightly reduced the
ability of the RNA to bind to DAI (25), whereas other results
(33) suggest that the central domain is the sole determinant of
DAI binding. Recently, the functional role of several elements
within the central domain was investigated by the construction
of a further series of small substitution and deletion mutants (26).
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Figure 5. Mobility of wild-type and mutant RNAs. Each labeled VA RNA was mixed with marker RNAs and subjected to electrophoresis in 7M urea/polyacrylamide
gels. Detection was by autoradiography.
To reassess the role of the central domain, we examined the
binding of these and other mutant RNAs to DAI (Fig. 6B, Fig.
4 and Table 2b).
Several of the central domain mutations reduced binding, but
in general they had less effect than the apical stem mutations,
and none of them abrogated binding. Mutations that substituted
sequences between nucleotides 101 and 117 (mutants Is3, Is3a,
sublOl,lO2, and .yuMlO-117) caused the least reduction in
binding and in some cases even increased binding (ranging
between 60 and 150% of control). Deletion of the same
nucleotides, in rf/103-109 and especially in rf/110-117, had a
greater effect (ranging from 14 to 49% of control) than
substitution of the sequence (ranging from 58 -102 % of control)
in Is3a and SMM10-117. Presumably, the removal of a segment
of the molecule causes a greater distortion in structure than its
substitution. All mutant RNAs containing a substitution at
nucleotides 118 and 119 (s«M18,119, J K M 0 2 , 1 1 8 , 1 1 9 ,
SMM01,102,118,119, and Mb), encroaching on conserved stem
4, exhibited modest reductions in binding (23 to 52% of wild-
type). Substitution of nucleotides 125-134 (Is5) also led to
slightly reduced binding (35 and 76% of wild-type). Truncation
of the VA RNA, molecule to 132 nucleotides in AatH RNA, by
deleting stem lb and loop 2b, generated a molecule with a
disrupted terminal stem and a slightly disturbed central domain.
These changes also reduced binding (12 and 50% of wild-type),
confirming that regions outside the apical stem can influence
binding, albeit usually to a lesser extent.
Differential effects of binding conditions
The data discussed to this point confirm the importance of the
apical stem for binding but modify our previous conclusion in
that several of the new mutants revealed an influence of the central
domain on binding. Comparison of RNA binding efficiency in
the two buffers, A and B, revealed some further distinctions.
It can be seen from Fig. 6A that, with most apical stem mutants,
differences between the buffers were minor. Exceptionally, three
VA RNAs (de/53-80, del49-60 and Isle) bound more than 20%
better in buffer A than in buffer B, indicating that in some cases
buffer B accentuates the requirement for the apical stem. The
binding of certain central domain mutant RNAs was also affected
by the buffer composition (Fig. 6B). Large differences were noted
with Is3, Is3a and sublOl,lO2, which bound much better in buffer
B, while sublQfc,118,119 and Is5, as well as AatH, bound better
in buffer A. These observations suggest that substitutions in the
central domain which do not disrupt any stem in the VA RNA]
molecule have no effect on binding in buffer B, whereas the
integrity of the central domain structure is much more important
for binding in buffer A. A good example is mutant Is5 RNA
which has a central domain digestion pattern similar to that of
wild-type VA RNA, but stem 3 cannot be formed (23,25). In
buffer A, Is5 RNA bound 76% as well as wild-type while in
buffer B it bound only 35% as well. Similarly, the binding
efficiency of Aatll RNA, which is deleted in stem 1 but is
structurally relatively normal in the central domain (data not
shown), bound 50% as well as wild-type VA RNA in buffer A
but only 12% as well in buffer B. Thus, it appears that binding
in buffer B is highly dependent on the integrity of the stem
structures forming the axis of the RNA molecule (i.e., stems 1,
3, 4 and 5), whereas binding in buffer A is more sensitive to
changes in the central domain. Perhaps a small stem-loop
structure or a more complicated tertiary structure element is
responsible for better binding to DAI in buffer A conditions.
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DISCUSSION
The protein kinase DAI is regulated by RNA effectors that cause
or prevent its activation. The RNA ligands bind to a site in the
protein's N-terminal region containing two repeats of a 67 residue
motif. This motif, the dsRBM, is found in a number of proteins
that bind dsRNA and structured single-stranded RNAs (30,31).
Despite growing understanding of the motif and its interaction
with RNA, the basis for the differential response of the kinase
to activators (such as dsRNA at suitable concentrations) and
inhibitors (such as VA RNAT) remains unknown. No DAI
mutant in the RNA binding domain has been reported to
discriminate between dsRNA and VA RNA (18,20,30,32),
implying that discrimination takes place subsequent to binding
of the RNA ligand. Consistent with this view, our analysis
indicates that a duplexed region of VA RNAT, its apical stem,
plays an important role in binding to DAI while a neighboring
structure, the central domain, is required to block enzyme
activation (25). On the other hand, studies by Ghadge and co-
workers (33,42) concluded that the central domain is responsible
for both binding the enzyme and inhibiting its activation. These
contrasting views were derived from examination of different
panels of VA RNA mutants. The interpretation of mutational
analyses of VA RNAj—DAI interactions is complicated by the
intricate and compact structure of the RNA inasmuch as mutations
may have long distance effects on RNA secondary and tertiary
structure. Because of the existence of a revised structural model
for VA RNA! (26—29) as well as new series of mutants in the
apical stem and central domain (26,34), we reexamined the
binding of VA RNAj to DAI.
Dependence of binding on ionic conditions
We observed quantitative and qualitative effects of the ionic milieu
on the binding efficiency of VA RNA to DAI. The binding of
wild-type VA RNAj to DAI decreased as the concentration of
KC1 or MgCl2 was increased, probably because cations compete
with basic groups of the protein for sites on the nucleic acid
backbone (i.e., phosphate groups) (43,44). Very similar salt
dependency was observed with p20, implying that the major
electrostatic interactions in the RNA-protein complex are
mediated by the basic N-terminal region of DAI, as proposed
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Table 2. Binding of VA RNA mutants to DAI
0.5 1.0 1.5
Binding relative to wild-type RNA
B
Wild-type
Is3
Is3a
Is3b
del103-109
sut>110-117
del110-117
sut>101,102
sub118,119
sub102,118,119
sub101,102,118,119
Is5
Aatll
y// /sss / / s / s / / s s yyy/ yy\
0 Buffer A
0 Buffer B
0.5 1.0 1.5
Binding relative to wild-type RNA
Figure 6. Binding of VA RNA, mutants to DAI. Mutant RNAs in the apical
stem (A) and the central domain (B) were labeled and reacted with immobilized
DAI. Binding was quantified by Cerenkov counting and is expressed relative to
the binding of wild-type RNA included as a control in each experiment. Background
binding obtained in the absence of DAI was subtracted. Error bars indicate standard
errors.
a) Apical stem mutants.
A2d!2
wild-type
Isle
Is1b
Isle
Is1a
Is1d
del73-84
del49-60
delS3-80
Binding to DAl'al
in Buffer
A B
++++ +++
+++ +++
+++ ++
++ ++
++ ++
++ ++
++ +
Kinase inhibition<b>
at (no/ml)
50 20 5
+ + + + + + + +
+ + + + + + + +
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+
Mobility
Group<c>
I
1
II
II
II
II
II
II
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b) Central domain mutants.
wild-type
sub101,102
Is3
Is3a
sub110-117
Is5
sub101,102,118,119
sub118,119
sub102,118,119
Is3b
deM03-109
Aatll
deM10-l17
aBinding data are summarized from Fig. 6. Relative to wild-type VA RNA,,
+ + + + represents >75% binding; + + + , 50-75%; + + , 25-50%; + ,
<25%.
bKinase inhibition data are from references (25,26): + + + , complete inhibition;
+ + , partial inhibition; + , slight inhibition; - , no inhibition.
cElectrophoretic data are from Table 1: group I, 27-33% retardation; group
II, 12-17% retardation; group III, 4 - 7 % retardation.
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by Green and Mathews (30). Calculations using the method of
Record et al. (43) suggest that about 5 monovalent counterions
are released upon the binding of VA RNA to either DAI or p20.
Although these measurements are not strictly quantitative, they
imply that the electrostatic interactions of DAI and p20 with VA
RNA] are similar.
The influence of ionic conditions was also evident when the
binding of certain VA RNA mutants was compared in two
different buffers. Wild-type VA RNA[ bound more efficiently
in buffer A than buffer B, consistent with the lower ionic strength
of the former. As a rule, the integrity of the central domain was
more critical in buffer A whereas the requirement for an intact
apical stem was emphasized in buffer B. Buffer A contains less
Mg2+ than buffer B, but this difference is partly compensated
for by the presence of Mn2+ in buffer A, so the different
behaviors of the mutant are hard to rationalize at the molecular
level. Nevertheless, these effects undoubtedly go some way to
explaining the conflicting observations made by Ghadge and
coworkers (using buffer A) and Mellits et al. (using buffer B).
Structure and function of VA RNA mutants
Table 2 summarizes the function of apical stem and central
domain mutants in terms of their ability to bind DAI and to inhibit
its activation, as well as their electrophoretic mobility. It is well
known that some nucleic acid structures, such as strong hairpins,
persist in sequencing gels despite the high concentration of urea
and elevated temperature. This can cause band compression (45)
and reflect significant intrinsic features of the molecule. For
example, chemical modification of tRNA, which normally
migrates more slowly than expected for its size, reduces its
secondary structure and thereby increases its mobility (46).
Several reports have noted that VA RNA also moves more slowly
than expected, and that this retardation is reduced by some
mutations (24,25,39,40) especially those located in the apical
stem. Data presented here suggest that the region responsible lies
in the distal part of this stem and that the effect is due to a structure
formed when an alternative pairing scheme is adopted by looping
out seven nucleotides (nucleotides 73—79), introducing a bulge
in the apical stem. Proximal to this bulge the pairing scheme is
unaffected, but distal to it the tip of the apical stem and loop
(nucleotides 55—72) is reorganized to form a different stem and
loop structure. This pairing scheme is similar to that observed
for A2dl2 (25), which lacks these six nucleotides, and is supported
by the data of Rohan and Ketner (40) who noted that point
mutations in the bulge and apical loop do not affect RNA mobility
whereas mutations elsewhere in the apical stem cause increased
mobility. The observation that in wild-type VA RNA some of
these nucleotides are somewhat sensitive to cutting by single-
strand specific nucleases in the presence of Mg2+ (unpublished
data) raises the possibility that this region is in equilibrium
between the bulged form and the structure shown in Figure 1
in physiological conditions.
Based on their mobilities, we classified the mutant RNAs into
three groups: group I showed the slow mobility of wild-type VA
RNA], group HI migrated nearly as fast as expected for
randomly coiled molecules, and group II occupied an intermediate
position. Group I contains the central domain mutants together
with AatH RNA (which is deleted in the terminal stem) and A2dl2
(which is deleted in the bulge region). All these RNAs can form
the A2dl2-type structure in the apical stem. Group II RNAs have
deletions or substitutions in the proximal part of the apical stem
between nucleotides 73 and 99, which affect the region below
the bulge but allow the tip of the apical stem-loop to adopt the
A2dl2-like structure. This apparently results in the reduced
stability of the structure but does not completely prevent it from
forming, hence the intermediate electrophoretic mobility.
Replacement of GC pairs with AU pairs in the base of the apical
stem is sufficient to destabilize the structure in Me RNA, which
is therefore a member of group II. Group HI RNAs have deletions
encroaching on nucleotides 55—72 which form the tip of the
reorganized A2dl2-like apical stem-loop: accordingly, these
RNAs retain little or no residual structure under electrophoresis
conditions. Inspection of Table 2 shows that most of the mutants
which display wild-type function belong to group I, but some
group II mutants (such as Me) were effective in binding assays
and were also able to rescue protein synthesis in vivo (34). Not
all group I mutants were as functional as wild-type RNA,
however. Therefore, the ability to form the A2dl2 type of
structure in the apical stem is not a good predictor of function
(although it correlates well with gel mobility) and it is unlikely
that this form of the RNA, if it exists in vivo, plays an important
role in VA RNA function.
Roles of the apical stem and central domain in DAI binding
Using an array of mutated VA RNAs we have defined more
precisely the contribution of the apical stem and the central
domain to the binding interactions of VA RNA with DAI. Our
previous results (25) suggested that efficient binding requires an
apical stem-loop structure and that efficient binding is not
sufficient for function. The present data, summarized
diagrammatically in Fig. 4, confirm that the primary DAI binding
site is in the VA RNA apical stem and show that the interaction
requires at least 8 base pairs of apical stem duplex. This
conclusion holds true in both buffers, A and B, and for deletions
and substitutions in the apical stem, and it is supported by results
obtained using footprinting techniques which show directly that
DAI and p20 protect the basal region of the apical stem (29).
The interaction seems to be favored by GC-rich sequences which
probably ensure stable apical stem base-pairing, since decreasing
its GC content or introducing mismatches within the apical stem
(e.g., in Isle and Mb) both adversely influence binding. A recent
study of the human TAR binding protein, TRBP-1, showed that
it also preferentially binds GC-rich stems (47) suggesting that
this may be a general feature of the dsRBM which is shared by
these two proteins.
Mutations in the central domain influenced DAI binding (Fig.
4), but the effects were not as easy to interpret, probably because
the structure of this region is less well understood and the
consequences of mutations are less predictable. Some mutations
in die central domain had no effect on binding or were even
stimulatory (at least in buffer B). Mutations in stem 4 consistently
reduced binding, as did mutations involving die substitution of
nucleotides 118 and 119 which encroach on the conserved
tetranucleotide CCCA. Deletions in the central domain had a
greater impact on binding than substitutions (compare dell 10-117
with subllO-117, for example), but the effects of buffer
composition complicate interpretation. Substitution mutants with
changes between nucleotides 110 and 133 fared better in buffer
B than buffer A, whereas the reverse was true for mutants with
changes between nucleotides 101 and 110. Deletion mutants were
equally affected in the two buffers, however. These phenomena
are probably attributable to subtle alterations in central domain
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structure, either at the secondary or tertiary level, due to the
presence of manganese ions and ATP in buffer A. We have
recently shown that the presence of magnesium alters the
conformation of VA RNAj (29). This shift is seen at both 2mM
Mg2+ (buffer A) and 10 mM Mg2+ (buffer B) but the effect of
Mn2+ on VA RNAj structure has not been analyzed. The
presence of ATP may also affect binding especially if regions
of DAI outside the RNA binding domain, such as the catalytic
site of DAI, are involved in the interactions with VA RNAj as
suggested by differences between DAI and the p20 fragment in
protection experiments (29).
Overall, we conclude that both the sequence and structure of
the central domain influence the binding of VA RNA to DAI,
and that the integrity and sequence of stem 4 in particular is
important for binding to DAI. Ghadge et al. (33) proposed that
the central domain was the critical feature responsible for the
interaction between VA RNA! and DAI. We have used two
different binding conditions to examine our mutations and still
find that the major interaction between the RNA and protein
occurs in the apical stem. The central domain substitution mutants
used by Ghadge et al. ranged from 9 to 17 nucleotides whereas
ours ranged from 2 to 9 nucleotides. Therefore, one possibility
is that there is an upper limit for the length of central domain
substitutions that can be tolerated by DAI which is not exceeded
by our mutations. It is of note that the smallest substitution mutant
(sub746) tested by Ghadge et al. encroaches on stem 4, where
even two nucleotide substitutions can disrupt binding. These
differences highlight a problem inherent in the use of large
mutations, and to some extent small mutations, to analyze highly
structured RNAs that interact with proteins. Changes introduced
into non-interacting regions may entrain long distance structural
alterations of regions involved in the RNA—protein interaction.
In this connection, it is significant that two experimental criteria
establish that the structural effects of our central domain mutations
are probably restricted to this region of the molecule.
Ribonuclease sensitivity data evidenced no major differences in
the cutting of the apical stem loop, and there were no major
changes in gel mobility indicative of disruption of pairing in the
apical stem or a gross rearrangement of RNA structure.
Relationship between binding and function
In general, apical stem mutants that bind well to DAI are also
able to block its activation in vitro (summarized in Table 2a).
This correlation of binding and function in vitro is exemplified
by deletion mutants cfe/49-60, del53-S0 and dl\, which are all
disrupted in the apical stem and can neither bind efficiently nor
function in vitro. Mutant deP3-84, which displays limited
binding, exhibited some in vitro function at higher concentrations
(34), whereas mutant A2dl2 which adopts an alternative pairing
scheme in the apical stem is the only deletion mutant that Junctions
well and also binds efficiently. Most of the apical stem substitution
mutants have also been tested in vivo (34) and show a similar
correlation between function in vivo and binding in vitro.
Exceptions are mutants Me and Mb, which do not bind as well
as wild-type RNA in vitro but nevertheless function efficiently
in vivo (34). Similarly, mutant dl\ RNA was shown previously
to bind poorly in vitro (25), consistent with the dependence on
the apical stem for binding in vitro, although this mutant RNA
functions well in vivo. Such discrepancies may indicate that the
conditions of the in vitro assays do not fully reflect those
pertaining in vivo, either because both buffer A and buffer B
compositions are suboptimal or because other components, such
as proteins or poly amines, which influence the interactions are
missing.
Central domain mutants did not show a clear correlation
between the binding of their RNAs to DAI and their function
in vitro. Our new data (Table 2b) are consistent with previous
observations suggesting that efficient binding is not sufficient to
block DAI activation by dsRNA (25). Mutants Is3, Is5 and Is3a
bound 50-100% as well as wild-type RNA but did not block
DAI activation. Other central domain mutants that did not bind
as well as wild-type RNA (e.g., ,SMM01,102,118,119,
swM02,118,119, suM10-117, and Je/103-109) still inhibitedDAI
but required higher concentrations to achieve the same degree
of inhibition. RNAs mutated in the conserved stem 4 bound DAI
with reduced efficiency, consistent with their reduced function
(28). They also bound slightly differently to full-length functional
DAI than to p20, in that fiill-length DAI appeared to be somewhat
less sensitive to mutations of this region than p20. Furthermore,
recent data indicate that these two proteins give slightly different
footprints in this region of the RNA (29). These observations
suggest that regions outside the RNA binding domain of DAI
contained in p20 can interact with the conserved stem. It is likely
that this interaction is functionally important and that non-
functional central domain mutants, which retain the ability to bind
to DAI, cannot correctly form this stem and are thus inactive.
In summary, we conclude that the apical stem of VA RNAj
is essential for DAI binding and that additional contacts with the
central domain also occur. Most of the central domain mutations
are less severe so the central domain contacts are probably not
required for initial binding of the RNA to the protein. Taken
together with information from footprinting analysis (29), it seems
that the principal interaction is between the apical stem and the
N-terminal RNA binding domain of DAI and that the central
domain makes further contacts with regions outside the RNA
binding domain. The conserved stem 4 is also important for
binding as all mutations within this region affect binding. These
findings are consistent with the hypothesis that VA RNA] first
binds to the RNA binding domain of DAI, then makes additional
contacts with other regions of the kinase thereby preventing its
activation. Current work is directed toward defining the nature
of the RNA-protein interactions involved in the binding of DAI
to its RNA effectors, and the mechanism by which they influence
the activity of the enzyme.
ACKNOWLEDGEMENTS
We thank Lisa Manche for expert technical help and Dr
A.Hovanessian for monoclonal antibody to DAI. This work was
supported by grant CA13106 from the National Institutes of
Health to MBM, and by a fellowship from Human Frontiers
Science Programme to PC.
REFERENCES
1. Mathews.M.B. and Shenk.T. (1991) J. Virol., 65, 5657-5662.
2. O'Malley,R.P., Mariano.T.M., SiekierkaJ. and Mathews,M.B. (1986) Cell,
44, 391-400.
3. Kitajewski.J., Schneider,R.J., Safer.B., Munemitsu,S.M., Samuel.C.E.,
Thimmappaya,B. and Shenk.T. (1986) Cell, 45, 195-200.
4. O'Malley,R.P., Duncan.R.F., Hershey.J.W.B. and Mathews,M.B. (1989)
Virology, 168, 112-118.
5. Schneider,R.J., Safer.B., Munemitsu.S.M., Samuel.C.E. and Shenk,T.
(1985) Proc. Natl. Acad. Sci. USA, 82, 4321-4324.
Downloaded from https://academic.oup.com/nar/article-abstract/22/21/4364/1101924
by Cold Spring Harbor Laboratory user
on 08 November 2017
4374 Nucleic Acids Research, 1994, Vol. 22, No. 21
6. Siekierka.J., Mariano.T.M., Reichel,P.A. and Mathews.M.B. (1985) Proc.
Nad. Acad. Sci. USA, 82, 1959-1963.
7. Hunter,!"., Hunt,T., Jackson.R.J. and Robertson,H.D. (1975) J. Biol. Chem.,
250, 409-417.
8. Minks,M.A., West,D.K., Benvin,S. and Baglioni,C. (1979) J. Biol. Chem.,
254, 10180-10183.
9. Manche,L., Green.S.R., Schmedt.C. and Mathews,M.B. (1992) Mol. Cell.
Biol., 12, 5238-5248.
10. Maran,A. and Mathews,M.B. (1988) Virology, 164 106-113.
11. Moldave.K. (1985) Ann. Rev. Biochem., 54, 1109-1149.
12. Pain.V.M. (1986) Biochem. J., 235, 625-637.
13. Proud,C.G. (1986) Trends in Biochem. Sci., 11, 73-77.
14. Hershey,J.W.B. (1989) J. Biol. Chem., 264, 20823-20826.
15. Hershey,J.W.B. (1991) Annu. Rev. Biochem., 60 717-755.
16. Thimmappaya,B., Weinberger.C, Schneider,R.J. and Shenk.T. (1982) Cell,
31 543-551.
17. Meurs,E., Chong.K., Galabru,J., Thomas,N.S.B., Kerr.I.M.,
Williams.B.R.G. and Hovanessian,A.G. (1990) Cell, 62, 379-390.
18. Katze.M.G., Wambach.M., Wong,M.-L., Garfinkel.M., Meurs,E.,
Chong.K., Williams,B.R.G., Hovanessian,A.G. and Barber,G.N. (1991)
Mol. Cell. Biol., 11, 5497-5505.
19. Mellits.K.H., Pe'ery.T., Manche,L., Robertson,H.D. and Mathews,M.B.
(1990) Nucl. Acids Res., 8, 5401-5406.
20. Green,S.R., Manche,L. and Mathews.M.B. (submitted).
21. Kostura,M. and Mathews.M.B. (1989) Mol. Cell. Biol., 9, 1576-1586.
22. Galabru,J., Katze.M.G., Robert.N. and Hovanessian,A.G. (1989) Eur. J.
Biochem., 178, 581-589.
23. Mellits.K.H. and Mathews.M.B. (1988) EMBO J., 7, 2849-2859.
24. Furtado.M.R., Subramanian,S., Bhat.R.A., Fowlkes.D.M., Safer.B. and
Thimmappaya.B. (1989) J. Virol., 63, 3423-3434.
25. Mellits.K.H., Kostura,M. and Mathews.M.B. (1990) Cell, 61, 843-852.
26. Pe'ery.T., Mellits,K.H. and Mathews,M.B. (1993) J. Virol., 67, 3534-3543.
27. Ma.Y. and Mathews.M.B. (1993) J. Virol., 67, 6605-6617.
28. Ma,Y. and Mathews.M.B. (in preparation).
29. Clarke.P.A. and Mathews.M.B. (submitted).
30. Green.S.R. and Mathews.M.B. (1992) Genes Dev., 6, 2478-2490.
31. St Johnston.D., Brown,N.H., Gall.J.G. and Jantsch.M. (1992) Proc. Natl.
Acad. Sci. USA, 89, 10979-10983.
32. McCormack.S.J., Thomis.D.C. and Samuel.C.E. (1992) Virology, 188,
47-56.
33. Ghadge,G.D., Swaminathan.S., Katze,M.G. and Thimmapaya.B. (1991)
Proc. Natl. Acad. Sci. USA, 88, 7140-7144.
34. Mellits,K.H., Pe'ery.T. and Mathews.M.B. (1992) J. Virol., 66, 2369-2377.
35. England.T.E. and Uhlenbeck.O.C. (1978) Nature, 275, 560-561.
36. Schmedt.C., Taylor.D.R., Manche.L., Green.S.R. and Mathews.M.B. (in
preparation).
37. Laurent,A.G, Krust,B., Galabru.J., Svab.J. and Hovanessian.A.G. (1985)
Proc. Natl. Acad. Sci. USA, 82, 4341-4345.
38. Katze,M.G., DeCorato.D., Safer.B., Galabru.J. and Hovanessian.A.G.
(1987) EMBO J., 6, 689-697.
39. Bhat.R.A. and Thimmappaya.B. (1985) J. Virol., 56, 750-756.
40. Rohan.R.M. and Ketner,G. (1987) J. Biol. Chem., 262, 8500-8507.
41. Kramer.F.R. and Mills,D.R. (1978) Proc. Natl. Acad. Sci. USA, 75,
5334-5338.
42. Ghadge.G.D., Malhotra.P., Furtado.M.R., Dhar.R. and Thimmapaya.B.
(1994) J. Virology, 68, 4137-4151.
43. Record.M.T.Jr., Lohman,T.M. and deHaseth.P. (1976) J. Mol. Biol., 107,
145-158.
44. Lohman,T.M., deHaseth.P.L. and Record,M.T.,Jr. (1980) Biochemistry,
19, 3522-3530.
45. Mills,D.R. and Kramer.F.R. (1979) Proc. NaU. Acad. Sci., 76, 2232-2235.
46. Hegg,L.A. and Thurlow.D.L. (1990) Nucl. Acids Res., 18, 2993-3000.
47. Gatignol.A., Buckler.C. and Jeang.K. (1993) Mol. Cell Biol., 13,
2193-2202.
Downloaded from https://academic.oup.com/nar/article-abstract/22/21/4364/1101924
by Cold Spring Harbor Laboratory user
on 08 November 2017
